Methods for targeting quadruplex DNA

Details for Australian Patent Application No. 2003226304 (hide)

Event Publications

7 August 2003 Complete Application Filed

Priority application(s): 60/456,637 20.03.03 US; 60/370,358 05.04.02 US; 60/404,966 20.08.02 US

4 December 2003 Application Open to Public Inspection

Published as AU-A-2003226304

27 April 2006 Change of Name(s) of Applicant(s), Section 104

The Arizona Board of Regents on behalf of the University of Arizona; Cyternex, Inc. The name of the applicant has been changed to The Arizona Board of Regents on behalf of the University of Arizona; Cylene Pharmaceuticals, Inc.

29 October 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.